147 related articles for article (PubMed ID: 11305700)
1. Which depressed patients respond to nefazodone and when?
Trivedi MH; Rush AJ; Pan JY; Carmody TJ
J Clin Psychiatry; 2001 Mar; 62(3):158-63. PubMed ID: 11305700
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
Elliott AJ; Russo J; Bergam K; Claypoole K; Uldall KK; Roy-Byrne PP
J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
[TBL] [Abstract][Full Text] [Related]
4. Nefazodone in the treatment of elderly patients with depressive disorders: a prospective, observational study.
Saiz-Ruiz J; Ibañez A; Díaz-Marsá M; Arias F; Carrasco JL; Huertas D; Martín-Carrasco M; Moreno I; Rico-Villademoros F
CNS Drugs; 2002; 16(9):635-43. PubMed ID: 12153334
[TBL] [Abstract][Full Text] [Related]
5. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
6. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
7. Symptom clusters as predictors of late response to antidepressant treatment.
Trivedi MH; Morris DW; Grannemann BD; Mahadi S
J Clin Psychiatry; 2005 Aug; 66(8):1064-70. PubMed ID: 16086624
[TBL] [Abstract][Full Text] [Related]
8. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
[TBL] [Abstract][Full Text] [Related]
9. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Marcus RN; Mendels J
J Clin Psychiatry; 1996; 57 Suppl 2():19-23. PubMed ID: 8626359
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
Feiger AD; Bielski RJ; Bremner J; Heiser JF; Trivedi M; Wilcox CS; Roberts DL; Kensler TT; McQuade RD; Kaplita SB; Archibald DG
Int Clin Psychopharmacol; 1999 Jan; 14(1):19-28. PubMed ID: 10221638
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
12. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
[TBL] [Abstract][Full Text] [Related]
13. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Rush AJ; Trivedi MH; Carmody TJ; Ibrahim HM; Markowitz JC; Keitner GI; Kornstein SG; Arnow B; Klein DN; Manber R; Dunner DL; Gelenberg AJ; Kocsis JH; Nemeroff CB; Fawcett J; Thase ME; Russell JM; Jody DN; Borian FE; Keller MB
Neuropsychopharmacology; 2005 Feb; 30(2):405-16. PubMed ID: 15578008
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB
J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
[TBL] [Abstract][Full Text] [Related]
15. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
Thase ME; Rush AJ; Manber R; Kornstein SG; Klein DN; Markowitz JC; Ninan PT; Friedman ES; Dunner DL; Schatzberg AF; Borian FE; Trivedi MH; Keller MB
J Clin Psychiatry; 2002 Jun; 63(6):493-500. PubMed ID: 12088160
[TBL] [Abstract][Full Text] [Related]
17. Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Kocsis JH; Rush AJ; Markowitz JC; Borian FE; Dunner DL; Koran LM; Klein DN; Trivedi MH; Arnow B; Keitner G; Kornstein SG; Keller MB
Psychopharmacol Bull; 2003; 37(4):73-87. PubMed ID: 15131518
[TBL] [Abstract][Full Text] [Related]
18. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
[TBL] [Abstract][Full Text] [Related]
19. Nefazodone: aspects of efficacy.
Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
[TBL] [Abstract][Full Text] [Related]
20. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Schatzberg AF; Rush AJ; Arnow BA; Banks PL; Blalock JA; Borian FE; Howland R; Klein DN; Kocsis JH; Kornstein SG; Manber R; Markowitz JC; Miller I; Ninan PT; Rothbaum BO; Thase ME; Trivedi MH; Keller MB
Arch Gen Psychiatry; 2005 May; 62(5):513-20. PubMed ID: 15867104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]